# Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation

> **NCT01352702** · PHASE4 · TERMINATED · sponsor: **Deutsches Herzzentrum Muenchen** · enrollment: 46 (actual)

## Conditions studied

- Coronary Heart Disease
- Atrial Fibrillation
- Acute Coronary Syndrome
- Atherosclerosis

## Interventions

- **DRUG:** Dabigatran
- **DRUG:** Phenprocoumon

## Key facts

- **NCT ID:** NCT01352702
- **Lead sponsor:** Deutsches Herzzentrum Muenchen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-05
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 46 (ACTUAL)
- **Why stopped:** Slow recruitment; Study was terminated for futility reasons
- **Last updated:** 2015-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01352702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01352702, "Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01352702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*